Thrive Earlier Detection envisions a future in which blood drawn at an annual physical is used to find early-stage cancer.
Thrive combines cutting-edge liquid biopsy technology with a machine learning engine to find multiple cancer types from a single blood draw — including many cancers that lack effective screening tools such as ovarian, pancreatic, liver cancers and others.
- Kenneth W. Kinzler, Ph.D.
- Nickolas Papadopoulos, Ph.D.
- Bert Vogelstein, M.D.
- We are thrilled to be included in @businessinsider's list of biotech companies to watch! We are committed to integr… https://t.co/O6xmhtS6w3
- Former Senator and Thrive consultant @ByronDorgan talks about cancer screening in today's @MorningConsult, discussi… https://t.co/TFiFj3jLuZ
- Take a listen: Thrive co-founder Dr. Bert Vogelstein spoke with @ARKinvest's Simon Barnett to talk about the histor… https://t.co/qjR2dpIAU3